A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/18803849

Download in:

View as

General Info

PMID
18803849